https://www.selleckchem.com/pr....oducts/Azacitidine(V
AIM Osteopontin (OPN) has been investigated as a biomarker for cancer and nonmalignant diseases during the last decades. Data about OPN as a potential biomarker in childhood diseases are still sparse, and reference values are not available in children. We aimed to establish reference values for children from birth to young adulthood and evaluate whether there are age-, gender-, and weight-specific differences. METHOD Umbilical cord blood and blood plasma samples of 117 children were collected in the Children's Hospital of Sa
Like
Comment
Share
